Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks
Sara A. Wahdan, Marwa O. El-Derany, Amany E. Abdel-Maged, Samar S. Azab
Topics & Concepts
InfliximabMedicineNeuroprotectionNeuroinflammationOxidative stressPharmacologyImmunologyInflammationTumor necrosis factor alphaInternal medicineCancer-related cognitive impairment studiesBrain Metastases and TreatmentGlioma Diagnosis and Treatment